XML 189 R74.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Share-based payments (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Share-based Payment Arrangements [Abstract] |
Explanation of effect of share-based payments on entity's profit or loss | The following share-based payment amounts are included in Operating costs in the income statements.
For the year ended December 31 | 2024 | 2023
RSUs and PSUs | (52) |  | (62) |
ESP and DSUs | (32) |  | (33) |
Total share-based payments | (84) |  | (95) |
Disclosure of number and weighted average exercise prices of other equity instruments | The following table summarizes RSUs/PSUs outstanding at December 31, 2024 and 2023.
Number of RSUs/PSUs | 2024 | 2023
Outstanding, January 1 | 3,412,812 |  | 3,124,187 |
Granted(1) | 1,236,690 |  | 1,125,502 |
Dividends credited | 284,530 |  | 213,427 |
Settled | (1,296,656) |  | (957,402) |
Forfeited | (58,476) |  | (92,902) |
Outstanding, December 31 | 3,578,900 |  | 3,412,812 |
Vested, December 31(2) | 1,090,574 |  | 1,225,815 |
(1)The weighted average fair value of the RSUs/PSUs granted was $50 in 2024 and $61 in 2023. (2)The RSUs/PSUs vested on December 31, 2024 were fully settled in February 2025 with BCE common shares and/or DSUs.
Disclosure of number and weighted average exercise prices of share options | The following table summarizes stock options outstanding at December 31, 2024 and 2023.
|  | 2024 | 2023
| Note | Number of options | Weighted average exercise price ($) | Number of options | Weighted average exercise price ($)
Outstanding, January 1 |  | 7,484,561 |  | 61 |  | 7,802,108 |  | 61 |
Exercised(1) | 30 | — |  | n.a. | (306,139) |  | 60 |
Forfeited or expired |  | (938,742) |  | 59 |  | (11,408) |  | 63 |
Outstanding and exercisable, December 31 |  | 6,545,819 |  | 61 |  | 7,484,561 |  | 61 |
(1)There were no stock options exercised in 2024. The weighted average market share price for stock options exercised in 2023 was $63.
Disclosure of range of exercise prices of outstanding share options | The following table provides additional information about BCE’s stock option plans at December 31, 2024 and 2023.
| Stock options outstanding
| 2024 | 2023
Range of exercise prices | Number | Weighted average remaining life (years) | Weighted average exercise price ($) | Number | Weighted average remaining life (years) | Weighted average exercise price ($)
$50-$59 | 3,390,928 |  | 3 |  | 58 |  | 4,291,180 |  | 3 |  | 58 |
$60 & above | 3,154,891 |  | 5 |  | 65 |  | 3,193,381 |  | 6 |  | 65 |
| 6,545,819 |  | 4 |  | 61 |  | 7,484,561 |  | 4 |  | 61 |

X
- Definition Share-based Payment Arrangements [Abstract] + References No definition available. + Details
Name: | bce_SharebasedPaymentArrangementsAbstract
Namespace Prefix: | bce_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the range of exercise prices for outstanding share options. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_d&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The explanation that enables users of financial statements to understand the effect of share-based payment transactions on the entity's profit (loss). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 50 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_50&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration